Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: Randomised controlled trial

Joakim Dillner, Susanne K. Kjaer, Cosette M. Wheeler, Kristján Sigurdsson, Ole Erik Iversen, Mauricio Hernandez-Avila, Gonzalo Perez, Darron R. Brown, Laura A. Koutsky, Eng Hseon Tay, Patricia García, Kevin A. Ault, Suzanne M. Garland, Sepp Leodolter, Sven Eric Olsson, Grace W.K. Tang, Daron G. Ferris, Jorma Paavonen, Matti Lehtinen, Marc StebenF. Xavier Bosch, Elmar A. Joura, Slawomir Majewski, Nubia Muñoz, Evan R. Myers, Luisa L. Villa, Frank J. Taddeo, Christine Roberts, Amha Tadesse, Janine T. Bryan, Roger Maansson, Shuang Lu, Scott Vuocolo, Teresa M. Hesley, Eliav Barr, Richard Haupt

Research output: Contribution to journalArticle

280 Scopus citations

Fingerprint Dive into the research topics of 'Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: Randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences